Publication entries for nasal spray
AAPS Journal. July 2013, Volume 15, Issue 3, pp 875-883 Bing V. Li, Feiyan Jin, Sau L. Lee, Tao Bai, Badrul Chowdhury, Hoainhon T. Caramenico, Dale P. Conner Abstract: Demonstrating bioequivalence (BE) for nasal spray/aerosol products for local action has been very challenging because the relationship between the drug in systemic circulation and the drug […]
Pharm Res. 2012 Nov;29(11):3122-30. doi: 10.1007/s11095-012-0804-7. Epub 2012 Jul 3. Doub WH1, Adams WP, Wokovich AM, Black JC, Shen M, Buhse LF. Corresponding author: firstname.lastname@example.org 1Division of Pharmaceutical Analysis, Food and Drug Administration CDER, OPS, St. Louis, Missouri, USA. ABSTRACT PURPOSE: To determine if cascade impactor (CI) measurement of drug in small particles from aqueous nasal sprays, described in FDA’s 2003 draft Nasal […]
Shaw CJ, Kulkarni VS, Smith M, Farina DJ, Pitluk Z, Goth W. Using Quality by Design approach to correlate patient usage to the in vitro performance of a nasal spray product. Respiratory Drug Delivery. 2012. Contact the Respiratory Drug Delivery for further information.
Pitluk ZW, Farina DJ, Pallas SR. A shaking control space for fluticasone propionate nasal spray SCU testing. Annual Meeting of the American Association of Pharmaceutical Sciences. 2012; Poster number M1153. Contact the American Association of Pharmaceutical Scientists for further information.
Chang BH, Pitluk ZW, Farina DJ. Development of a positive control on assessing the effects of bubble formation on actuation profiles for nasal spray drug delivery devices. Annual Meeting of the American Association of Pharmaceutical Sciences. 2011; Poster number T2346. Contact the American Association of Pharmaceutical Scientists for further information.
Liu X, Doub WH, Guo C. March 2011. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA). AAPS PharmSciTech 12(1):337-43. Contact the American Association of Pharmaceutical Scientists for further information.
Prince IR, Chang BH, Pitluk ZW, Farina DJ. Consideration of human actuation parameters on choice of appropriate drug and device combinations for nasal and aerosol delivery devices. Annual Meeting of the American Association of Pharmaceutical Sciences. 2010; Poster number T3230. Contact the American Association of Pharmaceutical Scientists for further information.
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 23(2):77-89 (April 2010). Makidon PE1, Nigavekar SS, Bielinska AU, Mank N, Shetty AM, Suman J, Knowlton J, Myc A, Rook T, Baker JR Jr. Corresponding author: email@example.com 1Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan 48109-5648, USA. Abstract Background: Many infectious diseases that cause significant morbidity and mortality, especially in the […]
Journal of Pharmaceutical Sciences, 99(4):2114-2122 (April 2010). Guo C1, Doub WH, Kauffman JF. Corresponding author: firstname.lastname@example.org 1Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, Missouri 63101 Abstract Design of experiment (DOE) methodology can provide a complete evaluation of the influences of nasal spray activation and formulation properties on delivery performance […]
Int J Pharm. 2010 Mar 30;388(1-2):82-7. doi: 10.1016/j.ijpharm.2009.12.041. Epub 2010 Jan 5. Liu X1, Doub WH, Guo C. U.S. Food & Drug Administration, Division of Pharmaceutical Analysis, 1114 Market Street, Room 1002, St. Louis, MO 63101, United States Abstract To determine aerosol deposition during the inhalation drug delivery, it is important to understand the combination of velocity […]